Annual report

Period2021-04-01 → 2022-03-31
Filed2022-06-23
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 163
MetricValuePeriodScopeSource row
Revenue¥2.77T2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥2.29T2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥2.23T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥2.32T2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥2.22T2017-04-01 → 2018-03-31dCons.Net sales (5-year summary)
Revenue¥2.19T2017-04-01 → 2018-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥215.0bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥137.1bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Ordinary income¥223.0bn2017-04-01 → 2018-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥251.1bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥137.8bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax¥130.5bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥188.4bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥240.8bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥162.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥46.0bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥30.9bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥118.0bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥126.0bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥133.8bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥186.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥68.1bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Net income¥54.4bn2019-04-01 → 2020-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥152.5bn2018-04-01 → 2019-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥178.2bn2017-04-01 → 2018-03-31dCons.Profit loss IFRS (5-year summary)
Total assets¥4.31Tat 2022-03-31Cons.Assets IFRS
Total assets¥3.99Tat 2021-03-31Cons.Assets IFRS
Total assets¥3.65Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥3.17Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥3.04Tat 2018-03-31dCons.Total assets (5-year summary)
Total assets¥3.07Tat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥2.61Tat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥2.51Tat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥1.70Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.48Tat 2021-03-31Cons.Equity IFRS
Net assets / equity¥1.39Tat 2020-03-31dCons.Equity IFRS
Net assets / equity¥1.28Tat 2018-03-31dCons.Net assets (5-year summary)
Equity (owners)¥1.22Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.02Tat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥924.0bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥998.7bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥927.1bnat 2018-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥365.4bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥360.9bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥180.6bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥201.7bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥231.9bnat 2018-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥231.9bnat 2018-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥171.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥374.5bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥106.0bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥208.1bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥288.4bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥293.3bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥115.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥177.4bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥499.7bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥180.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥156.7bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥154.5bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥81.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.0bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥373.5bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥60.9bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥88.1bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥94.3bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥99.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥28.162020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥18.912019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥72.172018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥77.132017-04-01 → 2018-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥81.812017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥72.122018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥77.092017-04-01 → 2018-03-31dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥81.772017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥745.03at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥623.39at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥565.13at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥610.82at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥563.53at 2018-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥567.04at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio28.3%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio25.5%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio25.3%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio31.5%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio30.3%at 2018-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio30.2%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE14.5%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE4.7%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE3.2%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE12.3%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE14.5%2017-04-01 → 2018-03-31dCons.Rate of return on equity (5-year summary)
ROE15.4%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees34,703at 2022-03-31Cons.Number of employees
Employees31,837at 2018-03-31dCons.Number of employees
Revenue¥797.4bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥646.0bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥678.4bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥723.6bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥708.4bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥14.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥13.5bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥68.5bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥38.1bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥28.9bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥73.7bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥75.9bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥57.5bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥49.5bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥61.7bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥41.7bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥22.8bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥67.0bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥55.8bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.74Tat 2022-03-31StandaloneAssets
Total assets¥1.73Tat 2021-03-31StandaloneAssets
Total assets¥1.58Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.50Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.46Tat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.37Tat 2022-03-31StandaloneLiabilities
Total liabilities¥1.38Tat 2021-03-31StandaloneLiabilities
Net assets / equity¥368.8bnat 2022-03-31StandaloneNet assets
Net assets / equity¥346.2bnat 2021-03-31StandaloneNet assets
Net assets / equity¥315.5bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥350.3bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥327.1bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥9.1bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥43.2bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥37.762021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.522020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.942019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥40.962018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥34.152017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥242021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥152020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥172019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥222018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥222017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥225.56at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥211.77at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥192.95at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥214.25at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥200.08at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio21.2%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio20.0%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio20.0%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio23.4%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio22.5%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE17.3%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE12.6%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE6.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE19.8%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE17.9%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,655,446,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,655,446,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,655,446,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,655,446,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,655,446,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees6,488at 2022-03-31StandaloneNumber of employees
Employees6,277at 2021-03-31StandaloneNumber of employees
Employees6,214at 2020-03-31dStandaloneNumber of employees
Employees6,096at 2019-03-31dStandaloneNumber of employees
Employees6,005at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 105
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2021-04-01 → 2022-03-31¥6.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2022-03-312674 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2022-03-31¥129.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2022-03-31¥67.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2022-03-31¥62.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥335.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2022-03-31¥15.8bn
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥7.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥87.7bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥87.7bn
Reconciling Itemsreconcilingsegment assetsat 2022-03-31−¥3.2bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥16.4bn
Energy And Functional Materialsreportable segmentcapex2021-04-01 → 2022-03-31¥26.8bn
Energy And Functional Materialsreportable segmentemployeesat 2022-03-313016 pure
Energy And Functional Materialsreportable segmentrevenue2021-04-01 → 2022-03-31¥328.7bn
Energy And Functional Materialsreportable segmentrevenue external2021-04-01 → 2022-03-31¥316.4bn
Energy And Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥12.4bn
Energy And Functional Materialsreportable segmentsegment assetsat 2022-03-31¥356.9bn
Energy And Functional Materialsreportable segmentsegment profit2021-04-01 → 2022-03-31¥20.1bn
Health And Agriculture Relatedreportable segmentcapex2021-04-01 → 2022-03-31¥16.8bn
Health And Agriculture Relatedreportable segmentemployeesat 2022-03-317532 pure
Health And Agriculture Relatedreportable segmentrevenue2021-04-01 → 2022-03-31¥480.8bn
Health And Agriculture Relatedreportable segmentrevenue external2021-04-01 → 2022-03-31¥473.8bn
Health And Agriculture Relatedreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥7.1bn
Health And Agriculture Relatedreportable segmentsegment assetsat 2022-03-31¥841.7bn
Health And Agriculture Relatedreportable segmentsegment profit2021-04-01 → 2022-03-31¥42.3bn
Information Electronic Chemistryreportable segmentcapex2021-04-01 → 2022-03-31¥16.6bn
Information Electronic Chemistryreportable segmentemployeesat 2022-03-317822 pure
Information Electronic Chemistryreportable segmentrevenue2021-04-01 → 2022-03-31¥474.2bn
Information Electronic Chemistryreportable segmentrevenue external2021-04-01 → 2022-03-31¥473.7bn
Information Electronic Chemistryreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥447m
Information Electronic Chemistryreportable segmentsegment assetsat 2022-03-31¥501.4bn
Information Electronic Chemistryreportable segmentsegment profit2021-04-01 → 2022-03-31¥57.8bn
Medical Productsreportable segmentcapex2021-04-01 → 2022-03-31¥19.6bn
Medical Productsreportable segmentemployeesat 2022-03-317784 pure
Medical Productsreportable segmentrevenue2021-04-01 → 2022-03-31¥591.7bn
Medical Productsreportable segmentrevenue external2021-04-01 → 2022-03-31¥591.7bn
Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥15m
Medical Productsreportable segmentsegment assetsat 2022-03-31¥1.37T
Medical Productsreportable segmentsegment profit2021-04-01 → 2022-03-31¥61.7bn
Petrochemistryreportable segmentcapex2021-04-01 → 2022-03-31¥25.3bn
Petrochemistryreportable segmentemployeesat 2022-03-314536 pure
Petrochemistryreportable segmentrevenue2021-04-01 → 2022-03-31¥847.9bn
Petrochemistryreportable segmentrevenue external2021-04-01 → 2022-03-31¥842.5bn
Petrochemistryreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥5.4bn
Petrochemistryreportable segmentsegment assetsat 2022-03-31¥908.5bn
Petrochemistryreportable segmentsegment profit2021-04-01 → 2022-03-31¥53.5bn
—segment totalcapex2021-04-01 → 2022-03-31¥105.1bn
—segment totalrevenue2021-04-01 → 2022-03-31¥2.72T
—segment totalrevenue external2021-04-01 → 2022-03-31¥2.70T
—segment totalrevenue intersegment2021-04-01 → 2022-03-31¥25.3bn
—segment totalsegment assetsat 2022-03-31¥3.98T
—segment totalsegment profit2021-04-01 → 2022-03-31¥235.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2020-04-01 → 2021-03-31¥18.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2020-04-01 → 2021-03-31¥103.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2020-04-01 → 2021-03-31¥51.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2020-04-01 → 2021-03-31¥52.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2021-03-31¥320.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2020-04-01 → 2021-03-31¥12.8bn
Reconciling Itemsreconcilingcapex2020-04-01 → 2021-03-31¥8.7bn
Reconciling Itemsreconcilingrevenue2020-04-01 → 2021-03-31−¥71.9bn
Reconciling Itemsreconcilingrevenue intersegment2020-04-01 → 2021-03-31−¥71.9bn
Reconciling Itemsreconcilingsegment assetsat 2021-03-31¥23.0bn
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥16.4bn
Energy And Functional Materialsreportable segmentcapex2020-04-01 → 2021-03-31¥23.0bn
Energy And Functional Materialsreportable segmentrevenue2020-04-01 → 2021-03-31¥254.5bn
Energy And Functional Materialsreportable segmentrevenue external2020-04-01 → 2021-03-31¥245.2bn
Energy And Functional Materialsreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥9.3bn
Energy And Functional Materialsreportable segmentsegment assetsat 2021-03-31¥322.3bn
Energy And Functional Materialsreportable segmentsegment profit2020-04-01 → 2021-03-31¥20.3bn
Health And Agriculture Relatedreportable segmentcapex2020-04-01 → 2021-03-31¥16.3bn
Health And Agriculture Relatedreportable segmentrevenue2020-04-01 → 2021-03-31¥428.0bn
Health And Agriculture Relatedreportable segmentrevenue external2020-04-01 → 2021-03-31¥423.0bn
Health And Agriculture Relatedreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥5.0bn
Health And Agriculture Relatedreportable segmentsegment assetsat 2021-03-31¥734.7bn
Health And Agriculture Relatedreportable segmentsegment profit2020-04-01 → 2021-03-31¥31.5bn
Information Electronic Chemistryreportable segmentcapex2020-04-01 → 2021-03-31¥12.2bn
Information Electronic Chemistryreportable segmentrevenue2020-04-01 → 2021-03-31¥432.4bn
Information Electronic Chemistryreportable segmentrevenue external2020-04-01 → 2021-03-31¥431.8bn
Information Electronic Chemistryreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥570m
Information Electronic Chemistryreportable segmentsegment assetsat 2021-03-31¥431.2bn
Information Electronic Chemistryreportable segmentsegment profit2020-04-01 → 2021-03-31¥39.7bn
Medical Productsreportable segmentcapex2020-04-01 → 2021-03-31¥14.0bn
Medical Productsreportable segmentrevenue2020-04-01 → 2021-03-31¥546.5bn
Medical Productsreportable segmentrevenue external2020-04-01 → 2021-03-31¥546.5bn
Medical Productsreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥13m
Medical Productsreportable segmentsegment assetsat 2021-03-31¥1.36T
Medical Productsreportable segmentsegment profit2020-04-01 → 2021-03-31¥71.7bn
Petrochemistryreportable segmentcapex2020-04-01 → 2021-03-31¥19.9bn
Petrochemistryreportable segmentrevenue2020-04-01 → 2021-03-31¥593.8bn
Petrochemistryreportable segmentrevenue external2020-04-01 → 2021-03-31¥589.3bn
Petrochemistryreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥4.5bn
Petrochemistryreportable segmentsegment assetsat 2021-03-31¥793.9bn
Petrochemistryreportable segmentsegment profit2020-04-01 → 2021-03-31−¥12.0bn
—segment totalcapex2020-04-01 → 2021-03-31¥85.4bn
—segment totalrevenue2020-04-01 → 2021-03-31¥2.26T
—segment totalrevenue external2020-04-01 → 2021-03-31¥2.24T
—segment totalrevenue intersegment2020-04-01 → 2021-03-31¥19.3bn
—segment totalsegment assetsat 2021-03-31¥3.65T
—segment totalsegment profit2020-04-01 → 2021-03-31¥151.2bn
Energy And Functional Materialsreportable segmentemployeesat 2022-03-311040 pure
Health And Agriculture Relatedreportable segmentemployeesat 2022-03-312002 pure
Information Electronic Chemistryreportable segmentemployeesat 2022-03-31803 pure
Medical Productsreportable segmentemployeesat 2022-03-3127 pure
Petrochemistryreportable segmentemployeesat 2022-03-311328 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 2,403
ItemContextValueUnit
Share of profit loss of investments accounted for using equity method IFRSCurrentYearDuration42180000000JPY
Impairment losses pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000PetrochemistryReportableSegmentMember1386000000JPY
Impairment losses pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember2604000000JPY
Impairment losses pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000InformationElectronicChemistryReportableSegmentMember3088000000JPY
Impairment losses pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000HealthAndAgricultureRelatedReportableSegmentMember14000000JPY
Impairment losses pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000MedicalProductsReportableSegmentMember910000000JPY
Impairment losses pl IFRSCurrentYearDuration_ReportableSegmentsMember8002000000JPY
Impairment losses pl IFRSCurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Impairment losses pl IFRSCurrentYearDuration_ReconcilingItemsMember109000000JPY
Impairment losses pl IFRSCurrentYearDuration8111000000JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000PetrochemistryReportableSegmentMember-JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember-JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000InformationElectronicChemistryReportableSegmentMember4000000JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000HealthAndAgricultureRelatedReportableSegmentMember-JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000MedicalProductsReportableSegmentMember-JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_ReportableSegmentsMember4000000JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Reversal of impairment loss pl IFRSCurrentYearDuration_ReconcilingItemsMember-JPY
Reversal of impairment loss pl IFRSCurrentYearDuration4000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_jpcrp030000-asr_E00752-000PetrochemistryReportableSegmentMember153473000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_jpcrp030000-asr_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember273000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_jpcrp030000-asr_E00752-000InformationElectronicChemistryReportableSegmentMember498000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_jpcrp030000-asr_E00752-000HealthAndAgricultureRelatedReportableSegmentMember8327000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_jpcrp030000-asr_E00752-000MedicalProductsReportableSegmentMember1085000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_ReportableSegmentsMember163656000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember128904000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant_ReconcilingItemsMember-2592000000JPY
Investments accounted for using equity method IFRSCurrentYearInstant289968000000JPY
Capital expenditures IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000PetrochemistryReportableSegmentMember25300000000JPY
Capital expenditures IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember26764000000JPY
Capital expenditures IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000InformationElectronicChemistryReportableSegmentMember16608000000JPY
Capital expenditures IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000HealthAndAgricultureRelatedReportableSegmentMember16818000000JPY
Capital expenditures IFRSCurrentYearDuration_jpcrp030000-asr_E00752-000MedicalProductsReportableSegmentMember19638000000JPY
Capital expenditures IFRSCurrentYearDuration_ReportableSegmentsMember105128000000JPY
Capital expenditures IFRSCurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember6503000000JPY
Capital expenditures IFRSCurrentYearDuration_ReconcilingItemsMember7892000000JPY
Capital expenditures IFRSCurrentYearDuration119523000000JPY
Merchandise and finished goods ca IFRSPrior1YearInstant348399000000JPY
Merchandise and finished goods ca IFRSCurrentYearInstant418228000000JPY
Raw materials ca IFRSPrior1YearInstant140190000000JPY
Raw materials ca IFRSCurrentYearInstant210592000000JPY
Work in process ca IFRSPrior1YearInstant22940000000JPY
Work in process ca IFRSCurrentYearInstant22538000000JPY
Inventories ca IFRSPrior1YearInstant511529000000JPY
Inventories ca IFRSCurrentYearInstant651358000000JPY
Land IFRSPrior1YearInstant87408000000JPY
Buildings and structures IFRSPrior1YearInstant247417000000JPY
Machinery and vehicles IFRSPrior1YearInstant281119000000JPY
Tools furniture and fixtures IFRSPrior1YearInstant28193000000JPY
Other components of property plant and equipment IFRSPrior1YearInstant82310000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass